{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:23:37Z","timestamp":1790900617246,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04912-7","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:50:25Z","timestamp":1777294225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case of novel meningoencephalomyelitis associated with vimentin IgG autoantibodies"],"prefix":"10.1186","volume":"26","author":[{"given":"Yi","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"3","key":"4912_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamaneurol.2024.4763","volume":"82","author":"D Wan","year":"2025","unstructured":"Wan D, Zhao S, Zhang C, et al. Novel meningoencephalomyelitis associated with vimentin IgG autoantibodies. JAMA Neurol. 2025;82(3):247\u201357.","journal-title":"JAMA Neurol"},{"key":"4912_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ceb.2015.02.004","volume":"32","author":"EM Hol","year":"2015","unstructured":"Hol EM, Pekny M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol. 2015;32:121\u201330.","journal-title":"Curr Opin Cell Biol"},{"key":"4912_CR3","doi-asserted-by":"publisher","first-page":"28293","DOI":"10.1038\/srep28293","volume":"6","author":"M Shigyo","year":"2016","unstructured":"Shigyo M, Tohda C. Extracellular vimentin is a novel axonal growth facilitator for functional recovery in spinal cord-injured mice. Sci Rep. 2016;6:28293.","journal-title":"Sci Rep"},{"issue":"7","key":"4912_CR4","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.4049\/jimmunol.1302911","volume":"192","author":"K Sasaki","year":"2014","unstructured":"Sasaki K, Bean A, Shah S, et al. Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells. J Immunol. 2014;192(7):3029\u201342.","journal-title":"J Immunol"},{"issue":"12","key":"4912_CR5","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1111\/cns.14336","volume":"29","author":"XL Li","year":"2023","unstructured":"Li XL, Wang JY, Li LK, et al. Epstein-Barr virus: to be a trigger of autoimmune glial fibrillary acidic protein astrocytopathy. CNS Neurosci Ther. 2023;29(12):4139\u201346.","journal-title":"CNS Neurosci Ther"},{"key":"4912_CR6","doi-asserted-by":"publisher","first-page":"578174","DOI":"10.1016\/j.jneuroim.2023.578174","volume":"382","author":"JR Zhang","year":"2023","unstructured":"Zhang JR, Zhuang S, Xu XD, et al. Overlapping Epstein-Barr virus encephalitis and autoimmune glial fibrillary acidic protein astrocytopathy. J Neuroimmunol. 2023;382:578174.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"4912_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1136\/jnnp-2022-330626","volume":"94","author":"D Liu","year":"2023","unstructured":"Liu D, Lin PH, Li HL, et al. Early autoimmunity and outcome in virus encephalitis: a retrospective study based on tissue-based assay. J Neurol Neurosurg Psychiatry. 2023;94(8):605\u201313.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"05","key":"4912_CR8","first-page":"731","volume":"40","author":"W Jingqi","year":"2019","unstructured":"Jingqi W, Cong Li, Chunping C, et al. A single-center-based retrospective clinical epidemiological analysis of multiple sclerosis. J Sun Yat-sen Univ (Med Sci). 2019;40(05):731\u20138.","journal-title":"J Sun Yat-sen Univ (Med Sci)"},{"issue":"7","key":"4912_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMra1904655","volume":"387","author":"DM Wingerchuk","year":"2022","unstructured":"Wingerchuk DM, Lucchinetti CF. Neuromyelitis optica spectrum disorder. N Engl J Med. 2022;387(7):631\u20139.","journal-title":"N Engl J Med"},{"issue":"9","key":"4912_CR10","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1073\/pnas.1017385108","volume":"108","author":"N Chihara","year":"2011","unstructured":"Chihara N, Aranami T, Sato W, et al. Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci U S A. 2011;108(9):3701\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"4912_CR11","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","volume":"90","author":"A Cobo-Calvo","year":"2018","unstructured":"Cobo-Calvo A, Ruiz A, Maillart E, et al. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. Neurology. 2018;90(21):e1858\u201369.","journal-title":"Neurology"},{"issue":"12","key":"4912_CR12","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140(12):3128\u201338.","journal-title":"Brain"},{"issue":"1","key":"4912_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","volume":"77","author":"P Waters","year":"2020","unstructured":"Waters P, Fadda G, Woodhall M, et al. Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes. JAMA Neurol. 2020;77(1):82\u201393.","journal-title":"JAMA Neurol"},{"issue":"3","key":"4912_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","volume":"19","author":"T Armangue","year":"2020","unstructured":"Armangue T, Oliv\u00e9-Cirera G, Mart\u00ednez-Hernandez E, et al. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. Lancet Neurol. 2020;19(3):234\u201346.","journal-title":"Lancet Neurol"},{"issue":"1","key":"4912_CR15","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","volume":"15","author":"S Jarius","year":"2018","unstructured":"Jarius S, Paul F, Aktas O, et al. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018;15(1):134.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"4912_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","volume":"21","author":"SA Goutman","year":"2022","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A, et al. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21(5):480\u201393.","journal-title":"Lancet Neurol"},{"issue":"11","key":"4912_CR17","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","volume":"73","author":"B Fang","year":"2016","unstructured":"Fang B, McKeon A, Hinson SR, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol. 2016;73(11):1297\u2013307.","journal-title":"JAMA Neurol"},{"issue":"2","key":"4912_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","volume":"81","author":"EP Flanagan","year":"2017","unstructured":"Flanagan EP, Hinson SR, Lennon VA, et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol. 2017;81(2):298\u2013309.","journal-title":"Ann Neurol"},{"issue":"6","key":"4912_CR19","doi-asserted-by":"publisher","first-page":"e653","DOI":"10.1212\/WNL.0000000000013087","volume":"98","author":"A Gravier-Dumonceau","year":"2022","unstructured":"Gravier-Dumonceau A, Ameli R, Rogemond V, et al. Glial fibrillary acidic protein autoimmunity: a French cohort study. Neurology. 2022;98(6):e653\u201368.","journal-title":"Neurology"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04912-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04912-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04912-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T22:50:06Z","timestamp":1781477406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04912-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4912"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04912-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7202305\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"382"}}